Gilead Sciences, a biopharmaceutical company, recently announced groundbreaking results from a late-stage trial of its experimental twice-yearly HIV prevention medicine, lenacapavir. The trial showcased a remarkable 100% effectiveness in preventing HIV transmission among approximately 2,000 women who received the injectable shot. This development has the potential to revolutionize HIV prevention strategies and expand Gilead’s presence
Hezbollah’s leader has recently made bold declarations, warning of a fight with “no rules and with no red lines” in the event of a full-out war with Israel. This statement comes in the midst of escalating tensions between the Lebanese militant group and Israel, with both sides engaging in cross-border fire. The conflict was further
Embracer Group’s annual report for 2023/2024 showcases a promising future for the company, particularly within its Entertainment & Services division. The division reported net sales of SEK7.08B ($678M), marking a significant 34% increase from the previous year. This positive growth trend is a testament to the company’s strategic initiatives and increased market demand for its
Gerrit Cole’s return to the New York Yankees for his season debut was met with high expectations, especially after his alarming elbow injury. The matchup against the Baltimore Orioles, the club’s primary competition for the American League East supremacy, was a tough challenge. However, Cole proved that he was up for the task, despite some
Following the success of Inside Out 2, Disney Head of Global Theatrical Distribution, Tony Chambers, expressed his gratitude towards exhibitors for their role in the record-breaking debut. The film grossed $295M worldwide in its opening weekend, with midweek numbers reaching $380M by Tuesday. Chambers commended the collective effort that contributed to the film’s success, highlighting